🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate whether metabolic modula...
Status
Completed
Location
Department of Cardiology, Aarhus Universityhospital, Skejby
Start Date
2007-10
Trial ID
NCT00549614
The purpose of the study is to examine whether a medication called acipimox...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2012-05
Trial ID
NCT01488409
Study investigates the hypothesis that an exercise programme of steady walk...
Status
Completed
Location
Liverpool John Moores University
Start Date
2020-01-06
Trial ID
NCT03809793
This study will test the hypothesis that reduction in release of free fatty...
Status
Completed
Location
Brigham & Women's Hospital
Start Date
2005-09
Trial ID
NCT00153179
The purpose of this study is to investigate signaling pathways in fat and m...
Status
Completed
Location
Department of medical endocrinology, University Hospital of Aarhus
Start Date
2011-01
Trial ID
NCT01299831
Treatments Being Tested
This study will investigate the non-growth-hormone-dependent metabolic effe...
Status
Completed
Location
University Hospital of Aarhus
Start Date
2012-06
Trial ID
NCT01209416
Growth hormone (GH) is essential for longitudinal bone growth and somatic d...
Status
Completed
Location
University Hospital of Aarhus
Start Date
2016-02-10
Trial ID
NCT02782208
Treatments Being Tested
Glucagon like peptide 1 is produced in enteroendocrine L cells in the small...
Status
Completed
Location
University Hospital of Aarhus
Start Date
2016-06
Trial ID
NCT02796950
Treatments Being Tested
Briefly, participants will be assessed for their eligibility for the study ...
Status
Unknown
Location
Liverpool John Moores University
Start Date
2019-10-01
Trial ID
NCT03804892
There is evidence that inhibition of FFA-release by acipimox is associated ...
Status
Completed
Location
Division of Endocrinology and Metabolism, Internal Medicine III, Medical University of Vienna
Start Date
2013-10
Trial ID
NCT01980524
Treatments Being Tested